Navigation Links
Research Pinpoints Brain's 'Gullibility' Center
Date:8/24/2012

By Barbara Bronson Gray
HealthDay Reporter

FRIDAY, Aug. 24 (HealthDay News) -- Whether it's an email from an unknown gentleman on another continent pleading for money or a financial scammer selling a promising penny stock, the young and old tend to be more easily duped than middle-aged people.

Now, researchers have pinpointed the area of the brain responsible for this gullibility and have theorized why it makes children, teens and seniors less likely to doubt.

The ventromedial area of the prefrontal cortex of the brain -- a softball-sized lobe in the front of your head, just above your eyes -- appears to be responsible for allowing you to pause after hearing or reading something and consider whether it's true, according to a study published recently in the journal Frontiers in Neuroscience.

"When most adults hear or read something, they believe it at first, and begin to process it," explained study author Erik Asp, a researcher in the department of psychology at the University of Chicago who conducted the study while at the University of Iowa. "And then they start asking questions. But we're all susceptible to believing something initially."

In children, the prefrontal cortex is still developing, not reaching full maturity until the late teens or even early 20s. As you age, the brain area responsible for doubting may begin to deteriorate, gradually reducing your propensity to question. The area is the last thing to develop in the brain and may be the first area to begin to show some decline, Asp explained.

"The decline in function is normal. It can happen at 60, 70 or 90," Asp said. "But we found that people with prefrontal cortex damage tend to be less likely to question, more prone to believing conspiracy theories and overall have less nuanced thinking."

Asp said it's important to know that signs of gullibility in teens and seniors are biologically based, and not the result of sloppy thinking. "They aren't someone's fault. Knowing it's a natural process may help people anticipate the problem and deal with it effectively," he noted.

In the study, the University of Iowa researchers selected 39 participants from its Neurological Patient Registry and 10 healthy people for comparison. They showed eight consumer ads to 18 people with focal brain damage to the ventromedial prefrontal cortex, 21 people with focal brain damage outside that area, and also to the healthy individuals.

Those with damage to the specific area of the prefrontal cortex were far more vulnerable to being deceived. They were more than twice as likely to believe misleading ads and were more inclined to purchase products advertised in those ads, as compared to those who had damage outside that area of the brain or who were healthy. This happened even when disclaimers saying the ads were misleading were visible.

The size of the damaged areas in the prefrontal cortex did not appear to affect an individual's tendency to doubt.

Asp explained that at the cellular level, cells called oligodendrocytes are responsible for putting myelin around a part of nerve cells called axons. Myelin insulates nerve fibers, not unlike how a household electrical wire insulates power. It permits the rapid transmission of impulses from nerve to nerve. Damage to myelin can cause some neurological diseases.

In the prefrontal cortex, one oligodendrocyte typically supports multiple axons. But in other parts of the brain, such as the posterior cortex, the average oligodendrocyte is only responsible for maintaining the myelin for a few cells.

Researchers theorize that the broader scope and responsibility of these cells in the prefrontal area of the brain has something to do with why there would be a decrease in doubting ability as people age. Understanding these cellular differences could potentially lead to a treatment target, Asp said.

"This research moves the science forward about understanding the mechanics of how people interpret untrue information," said Dr. Paul Sanberg, a distinguished professor in the College of Medicine at the University of South Florida, in Tampa. "It might make people more understanding of gullibility."

The bottom line, said Jordan Graffman, director of the brain injury research program at the Rehabilitation Institute of Chicago, is that families, friends and caregivers of older adults need to be available to support decision-making. "Being duped is more likely if you're isolated," he said.

More information

Learn more about your brain at the U.S. National Institute of Neurological Disorders and Stroke.

SOURCES: Erik Asp, Ph.D, researcher, department of psychology, University of Chicago; Paul Sanberg, M.D., Ph.D., distinguished professor, College of Medicine, University of South Florida, Tampa; Jordan Graffman, Ph.D., director, brain injury research program, Rehabilitation Institute of Chicago; July 2012 Frontiers in Neuroscience


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Moffitt Cancer Center researchers and colleagues identify PHF20, a regulator of gene P53
2. Circadian clock research may enable designer plants, and cancer and diabetes treatments
3. Research: NCAA football exploits players in invisible labor market
4. Canadian researcher is on a mission to create an equal playing field at the Paralympic Games
5. US risks losing out to Asia in medical research, U-M team warns
6. Dartmouth medical research closes in on new tuberculosis vaccine
7. Research presented at TCT 2012 will have significant impact on interventional cardiology
8. UNH researcher receives $360,000 to study strength training in elderly
9. Cramming for a test? Dont do it, say UCLA researchers
10. Likely voters say presidents first 100 days in office should include plans for research
11. Typical IBD patients not represented in research studies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research Pinpoints Brain's 'Gullibility' Center
(Date:4/28/2017)... SALT LAKE CITY, UTAH (PRWEB) , ... April ... ... Josée Côté as Account Manager for the North East region. Côté has 20+ ... operations and consulting. Prior to Phytomer, Côté worked with an array of high-end ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that has ... presence to an educational purpose as the host of the “Informed” series. The program ... a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis of ... field. Offering practical takeaways to apply immediately to IRR programs, the report highlights ...
(Date:4/27/2017)... Neb. (PRWEB) , ... April 27, 2017 , ... ... was named the 2017 North American CAREGiverSM of the Year for her extraordinary ... selects one of its 60,000 North American professional caregivers for the prestigious award ...
(Date:4/27/2017)... GA (PRWEB) , ... April 27, 2017 , ... Are ... a tragic spike in water-related accidents and drownings during the summer. While most of ... is that these situations occur every day. Very few people are taking the time ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology: